Cellectis S.A.
CLLS· Nasdaq
CLLSCellectis S.A.
Source filing unavailable
| Metric | Q2 2024 | Q2 2023 | Q2 2022 | Q2 2021 |
|---|---|---|---|---|
| Revenue | $8.06M | $178.00K | $1.35M | $11.18M |
| Net Income | -$25.27M | -$11.37M | -$18.95M | -$39.92M |
| EPS Diluted | -$0.28 | -$0.20 | -$0.42 | -$0.88 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Cellectis S.A. · CIK 1627281 · Engraved from SEC EDGAR
